About this trial
The goal of this observational study is to develop and evaluate an organ dysfunction score adapted to pregnancy and early puerperium (SOFA-OBS) that also incorporates a non-invasive tool to evaluate respiratory function (pulse oximeter).
The main question it aims to answer is: Does an organ dysfunction score adapted to pregnant and postpartum patients have a higher capacity to predict mortality than a non-adjusted organ dysfunction score? Participants: Patients requiring ICU (Intensive Care Units) admission, who are either pregnant or postpartum (up to 3 days after giving birth). The investigators aimed to include 130 participants.
The investigators will only collect participants' data and laboratory results that ICU doctor usually need for clinical practice. No additional interventions are required. Moreover, the investigators will evaluate if measuring participants' oxygenation through a non-invasive tool (pulse oximeter) is equally effective as measuring oxygenation by an arterial puncture.
Background: When managing severely ill patients in ICU, the investigators often use what it is called scores. Scores refer to a numerical value assigned to a patient's condition, which often predict outcome. The Sequential Organ Failure Assessment (SOFA) score is a scoring system that assess severity of organ dysfunction (in liver, kidney, blood pressure, respiratory, neurologic and platelets). It also identifies patients with severe infections (sepsis) and patients with bad outcomes.
Patients undergoing pregnancy or early postpartum develop physiological changes, such us a decrease in creatinine (a laboratory test measuring kidney function) and a decrease in blood pressure during the second trimester. These changes are not considered by the SOFA score. Actually, there is not an organ dysfunction score adapted to pregnant/postpartum patients to be used in the ICU. Moreover, a blood sample taken by arterial puncture is required to evaluate respiratory function by the SOFA score, which is a painful procedure. Instead, the investigators could evaluate respiratory function using a pulse oximeter, which measures peripheral oxygen saturation without needing an arterial puncture.
Potential benefits: A SOFA-OBS would hopefully become a more precise tool than general SOFA to evaluate organ dysfunction and to predict outcome among these patients. It would also help to detect sepsis earlier and treat it promptly, which might help reducing its mortality.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Pregnant (at any gestational age) or post-partum patients (at ≤3 days postpartum)
≥ 18 years old
Requiring admission to ICU for any reason
Staying in the ICU for ≥ 24h
Disqualifiers
Patients <18 years old
Non-pregnant patients
≥ 4 days postpartum
Patients or surrogates not giving consent to participate
Trial population
Patients will be recruited in ICUs from third level hospitals from Latin American countries.
Trial design
Cohort
Prospective
Treatments tested in this trial
Organ dysfunction score adjusted to obstetric patients (SOFA-OBS)
Other interventionThe obstetric SOFA (SOFA-OBS) adjusts renal and cardiovascular variables to physiological changes of pregnancy. Moreover, it simplifies respiratory evaluation, in terms of replacing arterial blood gases (ABG) for peripheral oxygen saturation/fraction of inspired oxygen (spO2/FiO2), when ABGs were not available. Variables unchanged during pregnancy (neurologic, hepatic and platelets), won't be modified.
Treatment groups
Trial outcomes
Primary outcomes
Obstetric patients ICU mortality
Non-surviving obstetric patients admitted to ICU during the study period/ all obstetric patients admitted to ICU during the same period
Sepsis-related obstetric ICU mortality
Non-surviving obstetric patients admitted to ICU during the study period, presenting sepsis on admission or developing sepsis during their ICU-LOS/All obstetric patients admitted to ICU during the same period, presenting sepsis on admission or developing sepsis during their ICU-LOS
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Daniela Vasquez
Lead sponsor
Argentinian Intensive Care Society
Sponsor institution